Melissa Fassbender’s recent article on Outsourcing Pharma tells us that diabetes drug development is riskier than most other drug development according to Tufts Center for the Study of Drug Development. Fassbender’s article has the data from Tufts’ study to share. ...
The Blue Ribbon Panel’s report, presented to the National Cancer Advisory Board on September 7th, describes 10 recommendations for the Cancer Moonshot goal of accelerating cancer research. Cancer Moonshot’s goal of 10 years of progress in 5 is bringing diverse...
Reminder to register for the October 3rd ACRP Circle City Chapter 16th annual fall symposium at the Ritz Charles in Carmel, IN. Pearl Pathways’ CEO and President Diana Caldwell will moderate a panel discussion of The Future of Research in Indiana. There will be...
The Indiana Clinical and Translational Sciences Institute (CTSI) is hosting its 8th annual meeting on September 23, 2016. A major highlight of the event will be the presentation of the Watanabe Prize in Translational Research to Dr. Robert Lefkowitz, a Nobel Laureate...
The culture of sharing and openness in the clinical trial data arena is improving – for sure, it’s being talked about. Large pharma and pharma associations are making pledges to make data collected more available. They are being careful to limit disclosure such that...
